Skip to content

Clinical trials

Bronchial Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bronchial Neoplasms Country / region: United States Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20131
20141
20164
20174
20181
20192
20215
20224
20232
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting8
Terminated6
Active, not recruiting3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Revolution Medicines, Inc.6
Blueprint Medicines Corporation3
Eli Lilly and Company3
Syndax Pharmaceuticals3
Hoffmann-La Roche2
Iovance Biotherapeutics, Inc.2
Weill Medical College of Cornell University2
ArriVent BioPharma, Inc.1
Daiichi Sankyo1
Sumitomo Pharma America, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bronchial Neoplasms27
Carcinoma, Non-Small-Cell Lung25
Lung Neoplasms25
Neoplasms24
Respiratory Tract Neoplasms23
Lung Diseases21
Thoracic Neoplasms21
Neoplasms by Site20
Respiratory Tract Diseases19
Carcinoma, Bronchogenic15

Trials

Showing 51 to 27 of 27. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.